MedPath

Lustre Pharmaceutical Lab. Co., Ltd.

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:0

Trial Phases

1 Phases

Phase 4:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Phase 4
2 (100.0%)

A Pharmacodynamic and Safety Study of BCS in Healthy Volunteers

Phase 4
Conditions
Healthy Volunteers
Interventions
First Posted Date
2015-11-03
Last Posted Date
2015-11-03
Lead Sponsor
Lustre Pharmaceutical Lab Co., Ltd
Target Recruit Count
20
Registration Number
NCT02594449
Locations
🇨🇳

The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China

An Efficacy Study of BCS Clearing the Oral Colonized Bacterium in Hospitalized Patients With COPD

Phase 4
Conditions
Chronic Obstructive Pulmonary Disease
Interventions
First Posted Date
2014-10-21
Last Posted Date
2014-10-21
Lead Sponsor
Lustre Pharmaceutical Lab Co., Ltd
Target Recruit Count
60
Registration Number
NCT02269800

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.